tiprankstipranks
Trending News
More News >
Strategic Divestment and Ambitious Targets Support Coherus Biosciences’ Buy Rating
PremiumRatingsStrategic Divestment and Ambitious Targets Support Coherus Biosciences’ Buy Rating
26d ago
Positive Outlook for Coherus Biosciences: Buy Rating Backed by Strong Growth and Strategic Milestones
Premium
Ratings
Positive Outlook for Coherus Biosciences: Buy Rating Backed by Strong Growth and Strategic Milestones
27d ago
Coherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift
Premium
Company Announcements
Coherus BioSciences: Q1 2025 Financial Highlights and Strategic Shift
27d ago
Coherus Biosciences price target lowered to $1.05 from $1.50 at UBS
PremiumThe FlyCoherus Biosciences price target lowered to $1.05 from $1.50 at UBS
2M ago
Coherus Biosciences CCO Resigns After UDENYCA Divestiture
Premium
Company Announcements
Coherus Biosciences CCO Resigns After UDENYCA Divestiture
2M ago
Coherus Biosciences Completes UDENYCA Franchise Divestiture
Premium
Company Announcements
Coherus Biosciences Completes UDENYCA Franchise Divestiture
2M ago
Coherus BioSciences’ Earnings Call: Growth and Challenges
PremiumCompany AnnouncementsCoherus BioSciences’ Earnings Call: Growth and Challenges
3M ago
Coherus Biosciences: Strategic Divestment and Pipeline Focus Justify Buy Rating
Premium
Ratings
Coherus Biosciences: Strategic Divestment and Pipeline Focus Justify Buy Rating
3M ago
Coherus BioSciences Reports 2024 Financial Growth
Premium
Company Announcements
Coherus BioSciences Reports 2024 Financial Growth
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100